Pfizer Inc.PFE
Close of Friday, October 23, 2026 · Pfizer Inc. is trading above its Pivot, OnlyAlpha's long-term trend line.
Price
$30.03
vs its Pivot
+12.5%
OnlyAlpha Score
78
Trend
Above its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| +5.7% | +26.8% | +30.0% | +5.1% | -1.2% |
Dividend: $1.72 a share over the last 12 months, a 5.73% yield at today's price.
Who runs and owns it
In these funds
Big investors that own it (latest 13F)
| Texas A&M / UT | 0.5% of holdings |
| CalPERS | 0.2% of holdings |
| New York State Common | 0.2% of holdings |
Suppliers, customers and partners
Sells to PFE
| 3SBio (HK-listed) | 2025 in-license |
| Halozyme | ENHANZE license |
Partners and deals
| BioNTech | COMIRNATY; 50/50 dev cost share |
| Bristol Myers Squibb | Eliquis |
| Astellas Pharma | Xtandi |
From the companies' own annual reports filed with the SEC.
Healthcare · Pharma
Get PFE in your free daily emailAfter every close: whether PFE is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track PFE free → Full Stock check
Track PFE free → Full Stock check